Key Takeaways
- AUM crossed INR 1,000 crore, up 149% YoY: The milestone quarter was driven by branch expansion (105 branches, +32 YoY) and a 71% jump in total income, while asset quality hit record lows.
- Co-lending is the FY27 growth lever: A partnership with Godrej went live mid-quarter, building INR 21 crore of AUM; management aspires to move 20% of the overall portfolio into co-lending by year-end, which would also improve the blended cost of funds.
- Cost of borrowing is sticky at 11.2%: Despite a credit rating upgrade to BBB+, macro headwinds and the journey to an A- rating mean management expects to merely maintain, not reduce, its average cost of borrowing in FY27.
- Gold loan resilience was tested and held: A sharp ~15% single-day gold price correction last quarter triggered margin calls but caused no stress or losses; the portfolio is stress-tested for 10–20% falls.
- What to watch next quarter: Whether the co-lending book scales toward the 20% aspiration, the pace of branch additions against a manpower constraint, and any quantification of the new cross-sell products (Arvog Wellness and the unnamed second offering).
AUM Growth & Branch Expansion
- 149% YoY AUM growth took the book from INR 439 crore to INR 1,096 crore, crossing the INR 1,000 crore milestone during Q4. Total quarterly income rose 71% to INR 69 crore and PAT grew 105%.
- Branch network grew ~50% to 105, with 32 branches added during the year. The primary constraint on branch-opening speed is manpower availability; each branch takes 30–45 days to open.
- FY27 branch target implies 150–160 branches, another ~50% expansion. Technology upgrades at the branch level are planned this year to reduce customer-journey TAT.
- Geographic expansion will be cautious: management will explore Odisha, Goa, and Maharashtra only after fully exhausting growth in existing South Indian catchment areas.
- Gold loan remains the core: even by FY29, gold loans will constitute the lion's share of AUM; Finkurve will remain a gold loan NBFC.
Naveen Kottala: "We will fully exhaust that and then move to a new geography."
Co-lending & the Liability Mix
- Co-lending went live mid-quarter with Godrej, building INR 21 crore of AUM in the first month. Two other partners (RBL and one more) have been onboarded.
- FY27 aspiration: 20% of overall AUM via co-lending. Achieving this would improve the blended cost of borrowing because co-lending partnerships carry a better cost than on-book borrowings, partially offsetting the macro uptrend in funding costs.
- 17 new lenders (banks and NBFCs) were added in FY26. NCDs now constitute ~35% of overall borrowings.
- Borrowings rose 3.5x from INR 237 crore to INR 833 crore, taking debt-to-equity from 1.1x to 2.4x. Management sees room to reach 4x–4.5x, excluding the off-book co-lending proportion.
- No equity raise planned for FY27: CRAR at 31% (vs a 15% regulatory minimum) and comfortable gearing mean a decision will only be revisited after H1 if scenarios change.
Naveen Kottala: "We aspire to achieve a 20% of the overall portfolio in co-lending by the end of the financial year. This is our aspiration. It is though it is early to say, but we aspire and make efforts to reach that stage."
Asset Quality & Gold Price Risk
- NPAs at record lows: gross NPA 0.13%, net NPA 0.09%. The year was "exceptionally good" on asset quality, aided by rising gold prices and the availability of top-ups.
- Gold price stress test passed: during a sharp ~15% single-day correction last quarter, margin calls were made but the margin call pool was not high; no stress or losses were observed. The portfolio is stress-tested for 10–20% falls.
- Month-on-month NPA resolution happens via repayment or, very rarely, auction. Management guides NPAs at the industry range and aims to stay within it.
Naveen Kottala: "We are comfortable in terms of stress test of even 15% to 20% as well. What happened, if you remember in last quarter there was time when the gold prices corrected almost on a single day the fall was almost 15% sharp, but we did not face any problem in terms of our portfolio."
Revenue Mix & the Personal Loan Book
- Personal loans are 3.9% of AUM but ~30% of revenue, making them the largest contributor to fee and commission expense (the biggest cost line after finance cost at ~INR 70 crore). This expense represents the outflow to fintech partners after Finkurve retains its hurdle rate.
- The PL book is capped at 10% of overall AUM. As it grows in proportion, the fee and commission expense will grow in proportion to both AUM and revenue.
- Fee income declined due to Ind AS regroupings, where a larger portion has been clubbed into interest income under amortized cost guidelines.
- Cross-sell launches are early-stage: the Arvog Wellness program issued over 150 policies in its initial phase, and a second, unnamed cross-sell product was introduced. Management declined to provide scale or contribution guidance, calling it premature.
Augmont Ecosystem & Inorganic Options
- Tangible benefit from Augmont: the lineage gives weightage when talking to banks, PSUs, and NBFCs, reflected in a better cost of funds compared to similarly sized NBFCs. Intangible benefits include brand weightage in the gold ecosystem.
- No direct financial benefit quantified in Arvog's numbers from the Augmont relationship when an analyst pressed for specifics on sourcing cost, customer acquisition, fraud rates, or collections.
- Augmont's ~3.7 crore+ digital gold customers remain untapped for gold loan sourcing; all current customers are sourced independently via the branch-led model. Management wishes to leverage this base in the future but gave no timeline.
- Inorganic acquisitions: management evaluates opportunities on an ongoing basis but has found nothing satisfactory on synergy or valuation. Options remain open on both the asset side and non-interest income side.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| AUM growth | 40–50% YoY (internal aspiration higher, but risk-adjusted) | FY27 |
| Branch expansion | ~50% growth (implied 150–160 branches) | FY27 |
| Co-lending share | 20% of overall AUM | FY27 exit |
| Cost of borrowing | Maintain ~11.2% | FY27 |
| Long-term ROE/ROA | 17–18% ROE, 3.5–4% ROA | Five-year horizon (steady-state) |
| AUM aspiration | INR 5,000 crore | By 2029 |
| Equity raise | None planned; revisit after H1 if scenarios change | FY27 |
| Agri product launch | In partnership with a bank via co-lending; talks ongoing | During FY27 |
Key Metrics
| Metric | Q4 FY26 |
|---|---|
| AUM | ₹1,096 cr, +149% YoY |
| Total quarterly income | ₹69 cr, +71% YoY |
| PAT growth | +105% YoY |
| Gross NPA | 0.13% |
| Net NPA | 0.09% |
| Capital adequacy ratio (CRAR) | 30.96% |
| Debt-to-equity | 2.42x |
| Cash and cash equivalents | ₹102 cr, ~8.3% of total assets |
| Average cost of borrowing (FY26) | 11.2% |
| ROE | 7.8% |
| ROA | 3.2% |
| Branch count | 105, +32 branches YoY from 73 |
| Average portfolio LTV | ~72% at year-end |
| Stage 1 portfolio (less than 30 DPD) | 99% of portfolio |
| Co-lending AUM | ₹21 cr, less than 2% of total AUM |
| Personal loan book share of AUM | 3.9% of overall AUM, contributing ~30% of overall revenue |
| Net worth | ₹346 cr |
| Total borrowings | ₹833 cr, up from ₹237 cr YoY |
| FY27 AUM growth guidance | 40% to 50% YoY |
| FY27 branch expansion guidance | ~50% growth, implying 150–160 branches |
| FY29 AUM aspiration | ₹5,000 cr |
| Long-term ROE target | 17% to 18% |
| Long-term ROA target | 3.5% to 4% |
| Co-lending AUM target (FY27) | 20% of overall AUM |
| Target debt-to-equity ratio | ~4x |